Renaissance Technologies
OKUR

Renaissance Technologies’s OnKure Therapeutics OKUR Stock Holding History

Renaissance Technologies’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
377,250
+129,900
+53% +$401K ﹤0.01% 2022
2025
Q4 		$717K Buy
247,350
+71,600
+41% +$214K ﹤0.01% 2427
2025
Q3 		$483K Buy
175,750
+53,114
+43% +$132K ﹤0.01% 2810
2025
Q2 		$293K Buy
122,636
+80,773
+193% +$212K ﹤0.01% 3048
2025
Q1 		$180K Sell
41,863
-5,587
-12% -$31.4K ﹤0.01% 3096
2024
Q4 		$408K Sell
47,450
-2,703
-5% -$40.9K ﹤0.01% 2937
2024
Q3 		$853K Buy
50,153
+5,933
+13% +$87.8K ﹤0.01% 2542
2024
Q2 		$668K Sell
44,220
-15,110
-25% -$256K ﹤0.01% 2548
2024
Q1 		$985K Buy
59,330
+19,290
+48% +$318K ﹤0.01% 2496
2023
Q4 		$641K Buy
40,040
+36,440
+1,012% +$2.27M ﹤0.01% 2666
2023
Q3 		$274K Sell
3,600
-2,511
-41% -$171K ﹤0.01% 2974
2023
Q2 		$401K Buy
6,111
+3,551
+139% +$286K ﹤0.01% 2987
2023
Q1 		$153K Sell
2,560
-1,160
-31% -$42K ﹤0.01% 3367
2022
Q4 		$87K Sell
3,720
-580
-13% -$15.4K ﹤0.01% 3666
2022
Q3 		$144K Buy
4,300
+2,000
+87% +$65.7K ﹤0.01% 3490
2022
Q2 		$61K Buy
+2,300
New +$53.5K ﹤0.01% 3963

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies's OKUR Position: Q1 2026 in Review

Renaissance Technologies increased its OnKure Therapeutics (OKUR) stake by 53% in Q1 2026, buying an estimated $401K and bringing the position to 377,250 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Renaissance Technologies first reported a position in OKUR in Q2 2022 and has held it in 16 quarters since. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Renaissance Technologies held 377,250 shares of OnKure Therapeutics worth $1.56M as of Q1 2026.
  • Renaissance Technologies bought 129,900 OnKure Therapeutics shares in Q1 2026, an estimated $401K.
  • OnKure Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2022 holding.
  • Renaissance Technologies first reported a position in OnKure Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.